Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06570538
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy Following Video-assisted Thoracoscopic Lobectomy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Analgesic Efficacy of an Opioid-free Postoperative Pain Management Strategy Versus a Conventional Opioid-based Strategy Following Video-assisted Thoracoscopic Lobectomy an Open-label Randomized Controlled Non-inferiority Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigators have designed a randomized controlled trial Utilizing an open-label randomized controlled study methodology this trial aims to explore a opioid-free safe and effective analgesic approach for thoracic surgery It also seeks to provide clinical guidance for the implementation of opioid-free or reduced-opioid postoperative analgesia in other thoracic procedures aiming to optimize postoperative pain management for patients and ultimately enhance the overall patients recovery experience
Detailed Description:
Patients who undergo thoracoscopic lobectomy are often at an elevated risk of opioid-related complications due to their reliance on opioids This overdependence not only decelerates the postoperative recovery process but also significantly increases healthcare costs Although there is a surge of interest in opioid-free anesthetic analgesia OFA for its potential to reduce adverse outcomes associated with opioid use there is a dearth of randomized controlled trials examining the efficacy of postoperative analgesia in patients undergoing thoracoscopic surgery Consequently the actual effectiveness of OFA in improving postoperative pulmonary complications and facilitating patient recovery remains unclear Its application is still in the exploratory phase with clinical practice lacking definitive guidelines to endorse or discard OFA as an alternative for postoperative analgesia in thoracoscopic surgery
To bridge this knowledge gap and evaluate the perioperative analgesic efficacy of OFA compared to traditionally used opioids in selected cancer patients undergoing thoracoscopic surgery investigators have designed a randomized controlled trial Utilizing an open-label randomized controlled study methodology this trial aims to explore a opioid-free safe and effective analgesic approach for thoracic surgery It also seeks to provide clinical guidance for the implementation of opioid-free or reduced-opioid postoperative analgesia in other thoracic procedures aiming to optimize postoperative pain management for patients and ultimately enhance the overall patient recovery experience
To bridge this knowledge gap and evaluate the perioperative analgesic efficacy of OFA compared to traditionally used opioids in selected cancer patients undergoing thoracoscopic surgery investigators have designed a randomized controlled trial Utilizing an open-label randomized controlled study methodology this trial aims to explore a opioid-free safe and effective analgesic approach for thoracic surgery It also seeks to provide clinical guidance for the implementation of opioid-free or reduced-opioid postoperative analgesia in other thoracic procedures aiming to optimize postoperative pain management for patients and ultimately enhance the overall patient recovery experience
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None